MYB Protein (AA 305-555) (His tag)
-
- Target Alle MYB Proteine anzeigen
- MYB (V-Myb Myeloblastosis Viral Oncogene Homolog (Avian) (MYB))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 305-555
-
Spezies
- Human
-
Quelle
- Escherichia coli (E. coli)
- Aufreinigungstag / Konjugat
- Dieses MYB Protein ist gelabelt mit His tag.
- Applikation
- Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
- Sequenz
- Thr305-Gln555
- Produktmerkmale
- Recombinant Transcriptional Activator Myb (c-Myb), Prokaryotic expression, Thr305-Gln555, N-terminal His Tag
- Reinheit
- > 97 %
- Top Product
- Discover our top product MYB Protein
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Isoelectric Point:5.6
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-80 °C
- Informationen zur Lagerung
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- MYB (V-Myb Myeloblastosis Viral Oncogene Homolog (Avian) (MYB))
- Andere Bezeichnung
- Transcriptional Activator Myb (MYB Produkte)
- Synonyme
- Cmyb Protein, c-myb Protein, c-myb_CDS Protein, efg Protein, AI550390 Protein, M16449 Protein, cmyb Protein, xmyb Protein, MYB proto-oncogene, transcription factor Protein, myeloblastosis oncogene Protein, MYB proto-oncogene, transcription factor S homeolog Protein, v-myb avian myeloblastosis viral oncogene homolog Protein, MYB Protein, Myb Protein, myb.S Protein, myb Protein
- Hintergrund
- MYB, Cmyb, C-Myb_CDS, Efg, Proto-oncogene c-Mybl, V-Myb Myeloblastosis Viral Oncogene Homolog
- Molekulargewicht
- 38kDa
- UniProt
- P10242
- Pathways
- Chromatin Binding, Positive Regulation of Immune Effector Process
-